Stimulation by neuropeptide Y of growth hormone secretion in prolactinoma in vivo (Q42527144)

1 November 2017

title

Stimulation by neuropeptide Y of growth hormone secretion in prolactinoma in vivo (English)

1 reference

1 November 2017

1 reference

Watanobe H

1

1 reference

1 November 2017

Tamura T

series ordinal

2

1 reference

1 November 2017

publication date

1 October 1996

1 reference

1 November 2017

1 reference

1 November 2017

volume

30

1 reference

1 November 2017

issue

5

1 reference

1 November 2017

page(s)

429-432

1 reference

Neuropeptide Y potentiates the luteinizing hormone (LH) response to LH-releasing hormone in men.

1 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4179%2896%2990005-0

7 January 2021

Neuropeptide Y directly inhibits growth hormone secretion by human pituitary somatotropic tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4179%2896%2990005-0

7 January 2021

Neuroendocrine significance of vasoactive intestinal polypeptide

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4179%2896%2990005-0

7 January 2021

Paradoxical response of growth hormone to peptide histidine methionine in acromegaly: comparison with the effects of thyrotropin-releasing hormone and vasoactive intestinal peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4179%2896%2990005-0

7 January 2021

Failure to confirm a growth hormone-releasing activity of corticotropin-releasing hormone in acromegaly: Comparison with the effects of other hypothalamic hormones

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4179%2896%2990005-0

7 January 2021

A further study on the stimulatory effect of peptide histidine methionine on growth hormone secretion in acromegaly: a dose-related study and a comparison with vasoactive intestinal peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4179%2896%2990005-0

7 January 2021

Clinical significance of the growth hormone response to vasoactive intestinal peptide and gonadotropin-releasing hormone in acromegaly

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4179%2896%2990005-0

7 January 2021

Stimulation of growth hormone by vasoactive intestinal polypeptide in acromegaly

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4179%2896%2990005-0

7 January 2021

Role of vasoactive intestinal polypeptide (VIP) in regulating the pituitary function in man

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4179%2896%2990005-0

7 January 2021

Vasoactive intestinal polypeptide enhances ACTH levels in some patients with adrenocorticotropin-secreting pituitary adenomas

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4179%2896%2990005-0

7 January 2021

Anomalous growth hormone response to vasoactive intestinal peptide and peptide histidine methionine in patients with prolactinoma or hypothalamic hyperprolactinemia

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4179%2896%2990005-0

7 January 2021

Physiologically significant effect of neuropeptide Y to suppress growth hormone release by stimulating somatostatin discharge

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4179%2896%2990005-0

7 January 2021

10.1016/S0143-4179(96)90005-0

Identifiers

DOI

1 reference

1 November 2017

1 reference